Use of glycogen phosphorylase inhibitors

Details Use of glycogen phosphorylase inhibitors Use of glycogen phosphorylase inhibitors

A - Human Necessities

61

K

A61K 31/404 (2006.01) A61K 31/00 (2006.01) A61K 31/407 (2006.01) A61K 31/4155 (2006.01) A61K 31/4178 (2006.01) A61K 31/422 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01) A61K 31/454 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 31/53 (2006.01) A61K 31/535 (2006.01) A61K 31/5377 (2006.01) A61K 31/54 (2006.01) A61K 31/55 (2006.01) A61K 45/06 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2341344

The invention provides medicines for treating prophylactically an individual in whom Type 2 diabetes mellitus has not yet presented, but in whom there is an increased risk of developing such condition, which comprise a glycogen phosphorylase inhibitor alone or in combination with a non- glycogen phosphorylase inhibiting anti-diabetic agent or an anti-obesity agent.

Affiliated with

Also associated with

Rating

Use of glycogen phosphorylase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of glycogen phosphorylase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of glycogen phosphorylase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1544057